Early breast cancer with positive margins: excellent local control with an upfront brachytherapy boost

Breast Cancer Research and Treatment
Thomas M SchroederMelanie Royce

Abstract

Standard breast conservation therapy consists of lumpectomy and whole breast radiation with boost. The effectiveness of radiation in cases of positive margins is controversial. Two potential treatment-related factors are time to initiation of radiation and localization of the boost. Here, we examine long-term outcomes of positive margin cases treated with an upfront interstitial brachytherapy boost. This particular treatment arrangement may reduce those treatment-related effects on local control. Historically, a low dose interstitial implant was a common boost technique. One approach administered the boost before external beam. A review of 521 cases treated at our institution was conducted. Patients were selected for this study if they received an upfront brachytherapy boost and had close or positive margins. Forty-four breast cancers were identified. Median follow-up of survivors was 11.3 years (8.1-21.7). Implant was performed at lumpectomy (12) or axillary dissection (32). Margin statuses were: focal carcinoma at ink (37), multifocal carcinoma at ink (1), carcinoma <1 mm from ink (2), and DCIS at ink (4). Median tumor size was 1.2 cm (0.5-3.5 cm). Ten patients had nodal involvement. Total median dose was 60 Gy (58.6-65.3 Gy)...Continue Reading

References

Jun 1, 1985·International Journal of Radiation Oncology, Biology, Physics·L J SolinR L Goodman
Feb 1, 1984·Radiology·C M Mansfield, W R Jewell
Aug 30, 1994·International Journal of Radiation Oncology, Biology, Physics·M MachtayG E Hanks
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C C ParkS J Schnitt
Oct 23, 2001·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M KokuboM Hiraoka
Aug 2, 2002·Breast Cancer Research and Treatment·N Hébert-CroteauJ Brisson
Feb 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jenny HuangWilliam J Mackillop
Feb 6, 2003·Cancer·Rashmi K BendaNancy Price Mendenhall
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Roland ReitsamerFlorentia Peintinger
Jan 31, 2006·International Journal of Radiation Oncology, Biology, Physics·Claire LemanskiJean-Bernard Dubois
Apr 10, 2007·International Journal of Radiation Oncology, Biology, Physics·Jose Luis GuinotLeoncio Arribas
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry BartelinkLaurence Collette
Dec 28, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Zheng ChenWilliam J Mackillop
Jan 18, 2008·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Felix SedlmayerUNKNOWN International Society of Intraoperative Radiotherapy
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ivo A OlivottoHagen Kennecke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
Q PanJ-L Lagrange
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Jose Luis GuinotLeoncio Arribas
© 2021 Meta ULC. All rights reserved